Barely Significant
← all excerpts

Efficacy and safety of supplementation of Exclzyme Pet for the management of arthritis and inflammatory symptoms in dogs: a randomized, double-blind, placebo-controlled pilot trial.

Front Vet Sci · 2026 · PMC13261630 · PMID 42290785

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantp < 0.0001actually significant
This difference was highly significant ( p < 0.0001), clearly demonstrating the superior therapeutic effect of Exclzyme Pet in helping the restoration of joint mobility in osteoarthritic dogs. 3.1.4 Willingness to hold contralateral limb The willingness to hold the contralateral limb during a lameness evaluation is a key clinical indicator, offering insight into the severity of pain, compensatory gait alterations, and the degree of joint inflammation.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.